|
| Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.28014
Tara Williamson, Michelle Carvalho de Abreu, Dimitri G. Trembath, Cory Brayton, Byunghak Kang, Thais Biude Mendes, Paulo Pimentel de Assumpção, Janete M. Cerutti, Gregory J. Riggins
|
| 1326-1338 |
|
| Esomeprazole enhances the effect of ionizing radiation to improve tumor control |
|
https://doi.org/10.18632/oncotarget.28008
Kassidy A. Hebert, Sergio Jaramillo, Wangjie Yu, Min Wang, Ratna Veeramachaneni, Vlad C. Sandulache, Andrew G. Sikora, Mark D. Bonnen, Ananth V. Annapragada, David Corry, Farrah Kheradmand, Raj K. Pandita, Michelle S. Ludwig, Tej K. Pandita, Shixia Huang, Cristian Coarfa, Sandra L. Grimm, Dimuthu Perera, George Miles, Yohannes T. Ghebre
|
| 1339-1353 |
|
| MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer |
|
https://doi.org/10.18632/oncotarget.28002
Christopher Kolios, Lakshmanan Sannachi, Archya Dasgupta, Harini Suraweera, Daniel DiCenzo, Gregory Stanisz, Arjun Sahgal, Frances Wright, Nicole Look-Hong, Belinda Curpen, Ali Sadeghi-Naini, Maureen Trudeau, Sonal Gandhi, Michael C. Kolios, Gregory J. Czarnota
|
| 1354-1365 |
|
| The use of a uPAR-targeted probe for photothermal cancer therapy prolongs survival in a xenograft mouse model of glioblastoma |
|
https://doi.org/10.18632/oncotarget.28013
Marina Simón, Jesper Tranekjær Jørgensen, Karina Juhl, Andreas Kjaer
|
| 1366-1376 |
|
| Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.28000
Maura Argenziano, Chiara Tortora, Alessandra Di Paola, Elvira Pota, Martina Di Martino, Daniela Di Pinto, Caterina Di Leva, Francesca Rossi
|
| 1377-1387 |
|
| Prokineticin-1 induces normal lymphangiogenic activity and is involved in lymphangiogenesis and lymph node metastasis in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.28016
Takayuki Naruse, Takanori Goi, Akio Yamaguchi
|
| 1388-1397 |
|
| Appropriate body mass index cutoffs for type 2 diabetes in Xinjiang population: defining the influence of liver aminotransferase |
|
https://doi.org/10.18632/oncotarget.28009
Jing-Yuan Xu, Long-Bao Yang, Zhi-Yi Han, Kai Wang, Zhen-Hua Yin, Ting Wu, Yong Shao, Xiao-Lan Lu
|
| 1398-1405 |
|
| Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment |
|
https://doi.org/10.18632/oncotarget.28010
Pareesa Kamgar-Dayhoff, Tinatin I. Brelidze
|
| 1406-1426 |
|
| Targeting cancer associated fibroblasts to enhance immunotherapy: emerging strategies and future perspectives |
|
https://doi.org/10.18632/oncotarget.27936
Christopher J. Hanley, Gareth J. Thomas
|
| 1427-1433 |
|
| A Dynamic Energy Budget (DEB) based modeling framework to describe tumor-in-host growth inhibition and cachexia onset during anticancer treatment in in vivo xenograft studies |
|
https://doi.org/10.18632/oncotarget.27960
Elena Maria Tosca, Maurizio Rocchetti, Paolo Magni
|
| 1434-1441 |
|
| Correction: Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes hypoxia-induced glioma migration and invasion |
|
https://doi.org/10.18632/oncotarget.28003
Yangyang Xu, Lin Zhang, Yuzhen Wei, Xin Zhang, Ran Xu, Mingzhi Han, Bing Huang, Anjing Chen, Wenjie Li, Qing Zhang, Gang Li, Jian Wang, Peng Zhao, Xingang Li
|
| 1442-1443 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
